Medical News

September 12, 2007 marks the tenth anniversary of a public hearing that was hoped to spark substantial changes in the way drugs are labeled for use during pregnancy. However, 10 years after the FDA recognized that the rules needed to be revamped, they have not yet been modified, resulting in anxiety on the part of physicians and patients and the unnecessary termination of wanted pregnancies. A position paper published online in Birth Defects Research Part A, the official journal of The Teratology Society, reviews the history and rationale behind the effort to change pregnancy labeling and calls for the immediate approval of new rules that have been proposed by the FDA. The journal is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/bdr……..

Original post by Health news from medicineworld.org

September 12, 2007 marks the tenth anniversary of a public hearing that was hoped to spark substantial changes in the way drugs are labeled for use during pregnancy. However, 10 years after the FDA recognized that the rules needed to be revamped, they have not yet been modified, resulting in anxiety on the part of physicians and patients and the unnecessary termination of wanted pregnancies. A position paper published online in Birth Defects Research Part A, the official journal of The Teratology Society, reviews the history and rationale behind the effort to change pregnancy labeling and calls for the immediate approval of new rules that have been proposed by the FDA. The journal is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/bdr……..

Original post by Health news from medicineworld.org